Journal of Biopharmaceutical Statistics · 2020 · 12 citations · 12 references
PharmacyCardiologyHealth InformaticsClinical Decision SupportClinical EpidemiologyRisk AssessmentAdverse Event AnalysisAdverse Event ReportingMedical Device Adverse Event ReportingMedical Device EvaluationSignal DetectionSignal EvaluationAdverse Event DetectionAlpha Spending FunctionsDevice Adverse EventDevice-related Adverse Event ReportingLeft Ventricular Assist DevicesMedical Device ReportingPost-market Safety SurveillanceRisk Signal Detection
Signal detection methods have been used extensively in post-market surveillance to identify elevated risks of adverse events. However, these statistical methods have not been widely used in detecting AE signals for medical devices. In this paper, we focused on the use of a likelihood ratio test (LRT)-based method in identifying adverse event (AE) signals associated with left ventricular assist devices (LVADs) using Medical Device Reporting (MDR) data. Among 110,927 adverse event entries identified in MDR data for LVADs, the LRT method detected 18 AE signals which included seven bleeding-related AEs such as hemolysis, thrombosis, hematuria, thrombus, blood loss, and hemorrhage. The LRT method was also applied to longitudinal data from 2007 to 2019 where a monotone alpha-spending function was used to ensure the control of type I error at each look and overall for trend analysis. Furthermore, the LRT method was compared to proportional reporting ratios (PRRs), Bayesian confidence propagation neural network (BCPNN), and simplified Bayes methods and found to be the most conservative method when examining the total number of detected signals, given its ability to control type-I error and the false discovery rate.
12